Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | HMGCR | P04035 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.32 |
| ▸ | DRD2 | P14416 | 1/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.31 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.31 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2216131 | 0.97 | FFAR3 (0.40) | FFAR3ALDH1A1TSHRCYP2D6CYP2C19 | |
| SCHEMBL4841349 | 0.87 | FFAR3 (0.36) | FFAR3ALDH1A1TSHRCYP2D6CYP2C19 | |
| SCHEMBL6011032 | 0.85 | FFAR3 (0.35) | FFAR3ALDH1A1TSHRCYP2D6CYP2C19 | |
| SCHEMBL2545646 | 0.84 | ALDH1A1 (0.41) | FFAR3ALDH1A1TSHRCYP2D6CYP2C19 | |
| Acetoacetic Acid SCHEMBL4622738 | 0.84 | FFAR3 (0.36) | FFAR3ALDH1A1TSHRCYP2D6CYP2C19 | |
| SCHEMBL5547489 | 0.79 | TDP1 (0.41) | FFAR3ALDH1A1TSHRCYP2D6CYP2C19 | |
| SCHEMBL7454835 | 0.78 | HDAC3 (0.46) | FFAR3ALDH1A1TSHRCYP2D6CYP2C19 | |
| SCHEMBL18125736 | 0.77 | TSHR (0.40) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL911270 | 0.77 | FFAR3 (0.42) | FFAR3ALDH1A1TSHRCYP2D6CYP2C19 | |
| SCHEMBL4140338 | 0.77 | TDP1 (0.42) | FFAR3ALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4077273-B1 | ALDIMINES AND USES THEREOF | BOSTIK SA (FR) | 2025-04-02 | — | — | EP | disclosed |
| US-20230400766-A1 | ONIUM SALT, RESIST COMPOSITION AND PATTERN FORMING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-12-14 | — | — | US | disclosed |
| US-20230357347-A1 | MODULATORS OF G-PROTEIN COUPLED RECEPTORS | CARMOT THERAPEUTICS, INC. | 2023-11-09 | — | — | US | disclosed |
| EP-4077446-B1 | POLYIMINES AND USES THEREOF | BOSTIK SA (FR) | 2023-08-23 | — | — | EP | disclosed |
| CN-116589375-A | Alcohol derivatives as Kv7 potassium channel openers | H.隆德贝克有限公司 | 2023-08-15 | — | — | CN | disclosed |
| CN-111727182-B | Alcohol derivatives as Kv7 potassium channel openers | H.隆德贝克有限公司 | 2023-05-26 | — | — | CN | disclosed |
| EP-4077446-A1 | POLYIMINES AND USES THEREOF | Bostik SA (FR) | 2022-10-26 | — | — | EP | disclosed |
| EP-4077273-A1 | ALDIMINES AND USES THEREOF | Bostik SA (FR) | 2022-10-26 | — | — | EP | disclosed |
| CN-114206328-A | Alcohol derivatives as Kv7 potassium channel openers for use in epilepsy or seizures | H.隆德贝克有限公司 | 2022-03-18 | — | — | CN | disclosed |
| WO-2021122595-A1 | POLYIMINES AND USES THEREOF | BOSTIK SA (FR) | 2021-06-24 | — | — | WO | disclosed |
| EP-1645657-A1 | METHOD FOR FORMING THIN FILM AND BASE HAVING THIN FILM FORMED BY SUCH METHOD | KONICA MINOLTA HOLDINGS, INC. (JP) | 2006-04-12 | — | — | EP | disclosed |
| EP-0558603-B1 | RETROVIRAL PROTEASE INHIBITORS | MONSANTO CO (US) | 1998-08-26 | — | — | EP | disclosed |
| US-5698569-A | Retroviral protease inhibitors | G. D. SEARLE & CO. (US) | 1997-12-16 | — | — | US | disclosed |
| US-5622949-A | AIDS THERAPY | G. D. SEARLE & CO. (US) | 1997-04-22 | — | — | US | disclosed |
| US-5620977-A | HUMAN IMMUNODEFICIENCY VIRUS | G.D. SEARLE & CO. (US) | 1997-04-15 | — | — | US | disclosed |
| US-5614522-A | SULFONAMIDE AND UREA-CONTAINING HYDROXYETHYLAMINE COMPOUNDS | G.D. SEARLE & CO. (US) | 1997-03-25 | — | — | US | disclosed |
| EP-0558673-B1 | RETROVIRAL PROTEASE INHIBITORS | MONSANTO CO (US) | 1996-04-17 | — | — | EP | disclosed |
| US-5475013-A | Inhibit human immunodeficiency virus protease | MONSANTO COMPANY (US) | 1995-12-12 | — | — | US | disclosed |
| EP-0513285-A1 | IMIDAZOL-2-YL DERIVATIVES OF SUBSTITUTED BICYCLIC COMPOUNDS AND PROCESS FOR THEIR PREPARATION. | ERBA CARLO SPA (IT) | 1992-11-19 | — | — | EP | disclosed |
| CN-1031533-A | Stable 1-Oxapenem-3-carboxylic acid | BAYER AG (DE) | 1989-03-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230357347-A1 | MODULATORS OF G-PROTEIN COUPLED RECEPTORS | GIPR, GLP1R, GCGR | FFAR3 61/4885ALDH1A1 3305/4885TSHR 140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.